EQIX vs OCUL · P/E 79, rev $5.07B vs rev $24.3M
Equinix Inc (EQIX) versus Ocular Therapeutix Inc (OCUL) — a side-by-side from cached financials, not a winner call.
Equinix Inc (EQIX) is a reit - specialty company listed on US.
Ocular Therapeutix Inc (OCUL) is a biotechnology company listed on US.
Latest reported EQIX revenue for 2026-06-30 was $5.07B. Net income was $894.0M. EQIX currently screens at market cap $74.23B and trailing P/E 79.4.
Latest reported OCUL revenue for 2026-06-30 was $24.3M. Net income was -$167.4M. OCUL currently screens at market cap $1.76B.
EQIX currently screens at market cap $74.23B and trailing P/E 79.4. OCUL currently screens at market cap $1.76B.
Not investment advice. Open the EQIX and OCUL stock pages for the full models.
Not investment advice.